|4Jun 1, 4:01 PM ET

Dudley Robert Michael 4

4 · Transcode Therapeutics, Inc. · Filed Jun 1, 2022

Insider Transaction Report

Form 4
Period: 2022-05-27
Dudley Robert Michael
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2022-05-27$1.84/sh+28,000$51,643871,114 total
  • Purchase

    Common Stock

    2022-05-31$1.87/sh+2,000$3,740873,114 total

Documents

1 file
  • 4
    tm2217388-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT